MapLight Therapeutics Inc. (MPLT)
NASDAQ: MPLTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
MPLT stock chart
Technical analysisKey statistics
All statistics- Market cap
- $520.19M
- EPS (TTM)
- -$6.25
- Dividend yield
- None
- 52-week range
- 8.92 – 40.43
- Day range
- 9.34 – 9.88
- Volume / Avg
- 275.18K / 867.94K
- Beta
- —
- Shares outstanding
- 52.85M
- Next earnings
- Nov 12, 2026
52-week range
MPLT stock today
MapLight Therapeutics (MPLT) closed at $9.36 on Oct 7, down 3.41% (-$0.33), versus the S&P 500's 0.22% decline. Trading was light, with 275.18K shares changing hands, about 32% of the average daily volume. Shares are 76.8% below their 52-week high of $40.43, set on Jul 10, 2026 and 4.9% above the 52-week low of $8.92, near the bottom of the past year's range.
MPLT is down 46.7% year to date, underperforming the S&P 500 (+14.0%). MapLight Therapeutics has posted a net loss over the last twelve months (EPS of -$6.25), so its P/E ratio is not meaningful. MapLight Therapeutics's next earnings report is expected on Nov 12, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About MapLight Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2025
Earnings
Earnings history- Next report
- Nov 12, 2026
MapLight Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NGNENeurogene Inc. | 25.87 | +1.65% | $517.69M | vs MPLT |
| ALTAltimmune Inc. | 2.66 | -0.37% | $517.42M | vs MPLT |
| OCSOculis Holding AG | 8.50 | -2.52% | $523.50M | vs MPLT |
| DRUGBright Minds Biosciences Inc. | 52.00 | +7.77% | $512.93M | vs MPLT |
| BLSMBlossomHill Therapeutics Inc. | 16.61 | -3.93% | $527.95M | vs MPLT |
| EOLSEvolus Inc. | 7.74 | +4.88% | $511.23M | vs MPLT |
| PBYIPuma Biotechnology Inc | 9.81 | +3.26% | $506.39M | vs MPLT |
| CBIOCrescent Biopharma Inc. | 13.49 | -0.59% | $501.11M | vs MPLT |
Indexes, lists and sector
MapLight Therapeutics stock FAQ
What is MapLight Therapeutics's stock price today?
MPLT last traded at $9.36 as of Oct 7, 4:00 PM EDT, down 3.41% on the day. Prices are delayed at least 15 minutes.
When is MapLight Therapeutics's next earnings date?
MapLight Therapeutics is expected to report earnings on Thursday, November 12, 2026.
What is the MPLT 52-week high?
The 52-week high for MPLT is $40.43 and the 52-week low is $8.92. The stock is currently 76.8% below its high.